Welcome to the Working Group on New TB Drugs Blog
Medecins Sans Frontieres/Doctors Without Borders Scientific Day May 10th
MSF Scientific Day is a unique opportunity to showcase medical and scientific research carried out in MSF programmes around the world. Presenting and debating the findings from our research is vital to improve the quality of our humanitarian programmes. There will be several topic s on tuberculosis.
Posted in Announcements, TB Drug Development, TB News, TB Prevention and Control Strategies
TB Edition of The Lancet Infectious Diseases
To commemorate World TB Day 2013, The Lancet Infectious Diseases publishes a Series of papers on tuberculosis, a disease that has long plagued human beings and was declared a global emergency in 1993 by WHO.
Posted in Announcements, Events, TB Drug Development, TB News, TB Prevention and Control Strategies
Get Ready for World TB Day March 24, 2013!
World TB Day is celebrated on March 24 and there is a lot going on during this week and next to highlight the continued problem of TB in the world and the solutions to address the problem. Included is a list of publications, news items, events, and links related to TB and World TB Day 2013.
Bedaquiline Receives Accelerated Approval from the FDA for MDR-TB Rx
The FDA granted Janssen’s TB drug Bedaquiline accelerated approval for treatment of MDR-TB. A link is provided to the FDA press release and Janssen’s full press release is included.
Multidrug-Resistance Tuberculosis: No Promises
A video from Medecins Sans Frontieres entitled “Multidrug-Resistance Tuberculosis: No Promises” on the situation of children affected with MDR-TB. It highlights the dire plight of children being treated for MDR-TB in Tajikistan.
FDA Advisory Committee recommends Janssen’s Bedaquiline for accelerated approval
Yesterday, Nov. 28th, the FDA Ant-infective Drug Advisory Committee voted to recommend Janssen’s Bedaquiline for accelerated approval for the treatment of MDR tuberculosis. A summary of the proceedings is included.
Recap from the 43rd Union World Conference in Kuala Lumpur
The week of November 12th was exciting with the 43rd Union World Conference, the WGND Annual Meeting (will be posting presentations soon), and the Stop TB Coordinating Board Meeting. Included are some news highlights and a listing of webcasts of interesting and presentations relevant for TB drug development and research.
WHO Releases Global Tuberculosis Report 2012
The WHO released the Global Tuberculosis Report 2012 today. The main highlights and additional coverage are included.
TB R&D Weekly Update: Delamanid Shows Promise against Multidrug-Resistant TB
This week, efficacy data from the recently completed Phase 2 randomized placebo-controlled trial in MDR patients evaluating delamanid with background treatment compared to placebo with background treatment was published yesterday in the New England Journal of Medicine. Delamanid (OPC-67683) is a new agent derived from the nitro-dihydro-imidazooxazole class of compounds that inhibits mycolic acid synthesis. The abstract and overview of news coverage are presented, as well as, additional links to TB R&D news.
Posted in Faces of TB, TB Patient Perspective, TB R&D Spotlight Interviews, TB Stigma, Voices from the Fight to Stop Tuberculosis, WGND Podcast Series
Community Engagement through Drama
Dr. Gill Black is the co-founder and Director of Health and Welfare at The Sustainable Livelihoods Foundation (SLF). In this inteview, we discuss with Dr. Black one of SLF’s groundbreaking projects that uses drama to engage local communities around issues related to TB and HIV/AIDS.
-
Toppix TB News- TB, a neglected disease in Uganda 15 May 2013
- Dr. John: Medications, T.B, tinnitus 8 May 2013
- U.S. non-profit group to build tuberculosis center in Pyongyang 4 May 2013
- Predictors of tuberculosis (TB) and antiretroviral (ARV) medication... 26 Apr 2013
- Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr.... 26 Apr 2013
